CompletedNCT00265330
Long-term ziprasidone treatment for young people with bipolarity
About this title
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Read the official source — NCT00265330Medication studyAges 10–17United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 10 years to 17 years. Other eligibility criteria applied.
- Listed locations
- Scottsdale and 40 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMarch 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 169
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 10 Years to 17 Years
- Official registry ID
- NCT00265330
- Official title
Show the full official title
26-Week Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Scottsdale · San Diego · Aurora
33 more locations
- Altamonte Springs
- Fort Lauderdale
- North Miami
- Orange City
- Tavares
- Decatur
- Honolulu
- Terre Haute
- Lexington
- Owensboro
- Shreveport
- Clinton Township
- Meridian
- St Louis
- Lincoln
- Omaha
- Albuquerque
- Rochester
- Cincinnati
- Cleveland
- Columbus
- Oklahoma City
- Tulsa
- Charleston
- Arlington
- DeSoto
- Lake Jackson
- Plano
- San Antonio
- Kirkland
- Spokane
- Milwaukee
- West Allis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Did this study involve medication?
Yes. The study involved medication, including Ziprasidone oral capsules.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 10 years to 17 years. Other eligibility criteria applied.
